Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Golden Meditech Announces FY2017/2018 Interim Results

Golden Meditech
Posted on: 30 Nov 17

Qinghe Hospital Achieves Revenue Contribution, Significant Growth in Healthcare Services Business
Strategic Roadmap in the Advanced Medical Fields to Diversify the Group's Business and Revenue Stream

HONG KONG, Nov. 30, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces today its interim results for the six months ended 30 September 2017 (the "Reporting Period").

For more information:
www.prnewswire.com/news-releases/golden-meditech-announces-fy20172018-interim-results-300564212.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.